Mortimer is President and co-owner of Oozoa Biomedical and has
many years of experience in the design and establishment of successful
assisted conception laboratories around the world. A native of Huddersfield
(Yorkshire, UK), after his tertiary education in the UK (BSc in
Zoology, Bristol University, 1974 and a PhD from Edinburgh University,
1977) he undertook postdoctoral training in Edinburgh (1977-1980),
Paris (1980-1981) and Birmingham (1981-1983) before being appointed
Assistant Professor in the Departments of Obstetrics & Gynaecology
and Medical Physiology at the University of Calgary in 1983, supported
by the Alberta Heritage Foundation for Medical Research. Between
1983 and 1991 his laboratory investigated human sperm pathophysiology
and, as Scientific Director of the Infertility Programme, he was
responsible for developing diagnostic andrology services, one of
the largest sperm banks in Canada and, from 1988, the IVF Programme.
He was promoted to Associate Professor in 1988, and cross-appointed
to the Department of Pathology in 1990. He taught each year in the
Reproductive System Course, was Course Chairman for 2 years and
Evaluation Coordinator for 1 year. In 1988-1991 he advised the World
Health Organization in preparing the 3rd (1992) edition of their
Laboratory Manual, and edited the first two editions of the Canadian
Fertility & Andrology Society's Donor Insemination Guidelines
(1988 and 1991).
In 1991 he moved
to Sydney (Australia) as the Scientific Director of Sydney IVF,
a position he held until his resignation in September 1999 to become
a full-time consultant. At Sydney IVF he was responsible for the
development of assisted reproduction laboratory services not only
in Sydney but at their other sites in Australia and around SE Asia.
During this time he developed new sequential IVF culture media and
incubators that provided Sydney IVF with the highest success rates
in Australia, and which have since been commercialized by Sydney
IVF as the Cook Culture System (Cook IVF, Brisbane, Australia).
In Sydney he held honorary appointments as Clinical Senior Lecturer
in the Department of Obstetrics & Gynaecology of Sydney University
and Visiting Principal Scientific Officer in the Department of Reproductive
Endocrinology & Infertility at the Royal Prince Alfred Hospital.
In 1997-1999 he worked on the World Health Organization's updated
Manual for the Standardized Investigation, Diagnosis and Management
of the Infertile Male.
From a business
perspective he has been Managing Director of Mortimer Scientific
Consulting Pty Ltd (1991-2000), a partner in Andrology International
BV (1992-1996), and Scientific Director and Board Secretary
of Launceston.SIVF Pty Ltd (1996-1999). He moved back to
Canada in March 2000 and formed Oozoa Biomedical Inc. In May 2000
was appointed to the Advisory Board of the Wildlife Breeding Resource
Centre (Pretoria, South Africa). He has been a Board Member of the Canadian Fertility & Andrology Society since 2001, currently serving as Secretary-Treasurer (until 9/2007).
Mortimer is well-known in the field of reproductive biology, having
authored or co-authored over 120 scientific publications, including
the book Practical Laboratory
Andrology (Oxford University Press, 1994) and Quality and Risk Management in the IVF Laboratory (Cambridge University Press, 2005) as well as over 200 conference presentations. He has given many invited lectures and
taught in workshops and courses worldwide. He is a member of 12
national or international professional societies and has served
on 4 Editorial Boards, including Human Reproduction (1989-1997).
He was Scientific Programme Chairman for the 11th World Congress
on In Vitro Fertilization and Human Reproductive Genetics held in
Sydney (Australia) in May 1999, and co-edited the plenary proceedings
volume Towards Reproductive Certainty: Fertility and Genetics
Beyond 1999 (Parthenon Press).
During the last
20 years he has undertaken a wide range of consultancy and advisory
work in various areas of reproductive biology and medicine in human,
domesticated and laboratory species covering products, equipment
and services from both the diagnostic and therapeutic perspectives.
Major projects have included setting up andrology laboratories,
sperm banks and IVF units, with a strong focus on staff training
and quality control programmes. Most recently this has included
advising on the development and implementation of quality and risk management programmes for ART centres.